Clinical Trial Update: Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating cusatuzumab in combination with background therapy for acute myeloid leukemia. The study is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Cusatuzumab (cusatuzumab)

Snippet

Sponsor: OncoVerity, Inc. | Conditions: Leukemia, Myeloid, Acute | Phase 1 | Status: ACTIVE_NOT_RECRUITING